This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hill-Rom Holdings' CEO Presents At Morgan Stanley Global Healthcare Conference (Transcript)

Hill-Rom Holdings, Inc. (HRC)

Morgan Stanley Healthcare Conference Call

September 11, 2012 1:30 pm ET


John J. Greisch – President and Chief Executive Officer

Mark Guinan – Chief Financial Officer


David R. Lewis – Morgan Stanley & Co. LLC


David R. Lewis – Morgan Stanley & Co. LLC

My name is David Lewis, I’m the medical device analyst here at Morgan Stanley. It’s my pleasure to have all of us here, yet again for the second year. I’ll show two members of management, obviously John Greisch, as many of you know, as well as Mark Guinan, and Andy is in the audience as all of you know.

What I was going to have, may be do, I should have talked about this. But you want to give us a quick preamble of the business, and then we jump into Q&A?

John J. Greisch

Sure, thanks, David, great to be here. Just few quick highlights for those of you that aren’t familiar with the story. Hill-Rom market leading medical technology company global market leader in the hospital bed area, we’ve got about 70% installed base market share here in the United States. We’ve got a portfolio of products really focused on patient safety, enhancing patient outcomes, improving caregiver productivity, and caregiver safety in addition to beds, therapeutic surfaces, patient lifting, devices to help mobilized patients, get patients in and out of hospitals faster.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.66 -0.09%
FB $118.57 0.84%
GOOG $698.30 0.76%
TSLA $241.82 0.44%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs